medical research queensland

Unsupported browser

The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.

• Mater Health
• Mater Education
• Mater Foundation

Search whole site

Celebrating 25 years of mater research.

Improving health outcomes through research discovery, translation and integration.

Key pancreatic protein linked to regulation of insulin production

Published in Nature Communications, Mater Researchers are one step closer to advancing diabetes treatment thanks to new research focusing on IL-22RA1—a protein receptor.

Help save lives through medical research

Make a donation through Mater Foundation or join our consumer health network and help shape the way research studies and clinical trials are conducted.

Our research programs

Meet our researchers

Student opportunities

Conducting research

We ask the questions and find the answers that save lives

Cancer | Mother and Baby | Chronic and Integrated Care Neuroscience  | Healthcare Delivery and Innovation

Our researchers give patients hope that their disease may one day be preventable or curable

Meet our nationally and internationally renowned biomedical and clinical researchers improving health across all of life’s stages. 

Celebrating Mater Research's achievements in 2023

Latest News

Mater launches cannabis trial for regional palliative care patients

New Mater stroke study helps survivors like Irene

Researcher decodes two-decade old mystery in molecular biology

Leading cancer researcher faces own diagnosis

Proudly collaborating with

• Contact QUT Contact QUT

Health research

Be part of research that has real impact, locally and on a global scale, and discover the projects establishing our staff as international research leaders.

Bold ideas, real impact

Our researchers, professor william parsonage.

Professor Will Parsonage is a clinical researcher focused on improving the healthcare provided to cardiology patients. He is Senior Staff Cardiologist at the RBWH and St Vincent’s and Clinical Director for the Australian Centre for Health Services Innovation.

See his snapshot

Dr Bridget Abell

Dr Bridget Abell is an implementation scientist and researcher with the Australian Centre for Health Services Innovation. She works with stakeholders to improve the delivery of health services, with a focus on cardiac rehabilitation.

See her profile

Distinguished Professor Lyn Griffiths

Distinguished Professor Griffiths is a respected molecular geneticist who has brought a translational focus to medical research to increase QUT’s influence and its impact on human health as director of the Centre for Genomics and Personalised Health.

Professor Steven McPhail

Professor Steven McPhail is Director of the Australian Centre for Health Services Innovation (AusHSI) and Academic Director of the Centre for Healthcare Transformation at the Queensland University of Technology, where he is the Professor of Health Services Research.

See his profile

Professor Jane Phillips

Professor Jane Phillips is the Head of the School of Nursing in our Faculty of Health. She leads an active program of palliative care research while building the research outputs of the early and mid-career academics.

• See her snapshot

Associate Professor Tony Kenna

Dr Tony Kenna is a cellular immunologist and a Senior Research Fellow at Queensland University of Technology. His research career has focused on human immunology and identification of novel therapeutic approaches for treatment of immune-mediated diseases.

Professor Danielle Gallegos

Professor Danielle Gallegos is the Chair of the Woolworths Centre for Childhood Nutrition Research funded by the Queensland Children’s Hospital Foundation. She has more than thirty years of experience as a practicing dietitian with fifteen of those as a public health nutritionist and ten years in academia.

Professor Gene Tyson

Professor Gene Tyson is an expert microbial ecologist and bioinformatician who has been at the forefront in the development and application of culture-independent molecular approaches that provide direct access to microbial 'dark matter'.

Professor Chelsea Watego

Professor Chelsea Watego is a Munanjahli and South Sea Islander woman with over 20 years of experience working within Indigenous health as a health worker and researcher. She is currently Professor of Indigenous Health at QUT’s School of Public Health and Social Work.

Professor Janet Davies

Professor Janet Davies is the assistant director of Research for Australia's largest hospital network, Metro North Hospital and Health Service, where she develops research strategy, policy, and chairs the clinical research education program.

Our strengths

Centre for healthcare transformation.

We bring together leading clinicians, health economists, statisticians and implementation scientists from a variety of fields, including nursing and other health sciences.

Centre for Genomics and Personalised Health

Our research spans the design, development, and application of methods for genomic discovery, analysis and translation to drive outcomes in the real world of clinical and personalised health.

Cancer and Palliative Care Outcomes Centre

Leading research to improve health outcomes for people affected by cancer and other chronic or life-limiting conditions.

Explore the centre

Australian Centre for Health Services Innovation

We are one of Australia’s leading health services research centres, with strengths in health economics, implementation science, statistics and data analysis.

Australia-China Centre for Tissue Engineering and Regenerative Medicine

An international network that aims to generate interdisciplinary awareness and promote and expand scientific cooperation and communication between China and Australia.

Centre for Biomedical Technologies

We aim to deliver better health in our lifetime, by improving how we treat complex medical cases stemming from injuries, infection and age-related issues. Our research focuses on better patient treatments and quality of life into the future.

Centre for Accident Research and Road Safety - Queensland

We conduct high-quality research and education to reduce road trauma, and inform the development of road safety countermeasures and policies to keep the community safe on the road.

Centre for Immunology and Infection Control

An inter-disciplinary and cross-sectoral innovation hub to investigate and develop tools to diagnose, prevent and treat diseases resulting from immune dysregulation or pathogen infection.

Centre for Microbiome Research

We develop novel culture-independent molecular approaches and bioinformatics tools to answer important questions about the role of microbial communities in human and environmental health.

Centre for Vision and Eye Research

We are shaping the future of vision through our research and working to address vision problems affecting everyday Australians.

Our research groups and projects

48 matching research projects.

Displaying 1 - 6 of 48 matching research projects

Displaying 1 - 6 of 48 research projects

Researchers from across many disciplines conduct their research in QUT Health Clinics facilities.

Explore QUT Health Clinics research

Participate in research

You can help us to discover new knowledge, create innovations and develop solutions for real-world challenges.

Study with us

Be a part of a more progressive, collaborative approach to research and contribute to your field, progress into academia or grow your career.

Work with our students

Research student internships bring a fresh perspective, new skills and innovative approaches to your workplace.

How it works

Our facilities

Explore our cutting-edge health facilities.

Research news

Diabetes footcare project awarded $1.3M to evaluate novel rural outreach services

The project, Queensland Diabetes Footcare Hubs (Q DFootHubs), has received $1,363,466.75 from the National Health and Medical Research Council (NHMRC) under its Partnership Projects program.

Launch of world first patient registry for Australia’s most common genetic disorder

People with haemochromatosis now have the opportunity to join the world’s first cloud-based patient registry aimed at advancing research and understanding of the potentially life-threatening, inherited iron-overload condition.

“What” not “where” – that is the research question

A QUT statistician has called for a novel way to shift the focus from where academic research is published to what the research has actually found.

• Skip to content
• Queensland’s research capability
• Key science areas

Health and medical science

Professor Chamindie Punyadeera, Griffith Institute for Drug Discovery – Leading researcher in saliva diagnostics, proteomics, and cortisol

• Over 100 employees health and medical research centres
• 3 times global average cited for AI-enabled healthcare
• 9 research hospitals across Queensland
• 361 million private manufacturing R&D investment annually

Queensland has an advanced research-informed healthcare system with world class health professionals, renowned researchers and state of the art facilities. Recent testaments to our highly collaborative, innovative, and well supported environment for conducting leading health and medical research include the development of the world’s first human papilloma virus vaccine, the mRNA vaccine and molecular clamp technology, and at-home non-prescription diagnostic kits for COVID-19. While many Queensland health and medical researchers re-prioritised their research on potential vaccines, treatments and other medical interventions in response to the COVID-19 pandemic, other researchers have applied their expertise to other impacts of the pandemic upon our economy and other aspects of society.

AI-enabled healthcare includes analysis of the large volumes of personal and system-wide clinical data, management of electronic medical records, use of wearable devices, diagnostic imaging and genomics. In AI-enabled healthcare alone, Queensland researchers produced over 89,000 publications between 2017 and 2021, and the most recent of these (in 2020) were cited 3 times the global average (citation rate of attributable publications), with more than 1200 of these linked to patent publications. Queensland AI-enabled healthcare researchers collaborate most frequently with the USA (33%); the UK (25%); China (18%); Canada (12%), and Germany (11%).

Queensland has a network of infectious disease scientists and clinicians recognised internationally for research excellence that is supported by world-class infrastructure. The Queensland Infectious Disease Research Capabilities (PDF, 799.9KB) document provides comprehensive audit of infectious disease research capabilities across the Griffith University, QIMR Berghofer, University of Queensland, Queensland University of Technology, Bond University, University of the Sunshine Coast, James Cook University and the Translational Research Institute.

Queensland has world-leading researchers in areas such as:

• viral, bacterial and parasitic infection
• vaccine research and drug discovery
• genomics and personalised medicine
• digital and AI-enabled healthcare
• imaging and imaging technology
• cellular and molecular neuroscience
• advanced therapies for cancer

and has one the world’s leading high-risk pregnancy units.

Five out of Queensland’s nine universities have been rated ‘above’ or ‘well above’ world standards for medical and health sciences by the Australian Research Council.

Queensland boasts a critical mass of leading health and medical research precincts, institutes, and centres and over 140 research organisations involved in health and medical research. Queensland has nine universities – including three of Australia’s largest – all with strong research linkages with Queensland’s research hospitals and dedicated world-class research institutes and centres.

Leading health and medical research centres

All health and medical research centres

Industry-research collaboration and commercialisation

Vaccine development.

Millions of lives will be saved from cervical cancer by the Human Papilloma Virus (HPV) vaccine Gardasil® that was developed at the University of Queensland by Professor Ian Frazer and the late Dr Jian Zhou to reduce the incidence of cervical cancer. Now produced by Merck Vaccines Gardasil® has led to a 90% decrease in the prevalence of HPV.

Diagnostic imaging

Most of the MRI scanners in the world use magnetic resonance technology research by Queensland Centre for Advanced Imaging . The Translational Research Institute (TRI) collaboration with the Siemens Healthineers enables researchers and clinicians to use advanced medical imaging without the need for invasive testing.

A universal vaccine for Malaria – a disease that annually causes over 200 million clinical episodes and more than 600,000 deaths has been developed by JCU’s Australian Institute for Tropical Health and Medicine (AITHM), is in clinical development in a project led by AITHM in collaboration with Townsville University Hospital , DMTC Ltd and Pfizer .

AI-enabled healthcare

In a project aimed at using AI and whole-genome sequencing to predict patient outcomes of cancer treatment, the QIMR Berghofer have partnered with Brisbane-based AI technology company, Max Kelsen , precision analytics firm, genomiQa , genome sequencing company, BGI Australia , and the Royal Brisbane and Women’s Hospital .

Personalised medicine

Fast-tracking of research into potential new lung cancer drug treatments has begun at the Centre for Genomics and Personalised Health in a partnership with Janssen Pharmaceutica NV that provides access to their Jump-stARTer Compound Library.

An acute-care bed dashboard to visualise unit bed capacity, patient status and care trajectory has been developed by Datarwe , a public-private collaboration with Griffith University , Gold Coast University Hospital , Queensland AI Hub and other healthcare providers and leading healthcare ecosystem partners.

Medical devices

The easily stored and administered needle-free vaccine delivery technology developed by researchers at the Australian Institute for Bioengineering and Nanotechnology has been commercialised by UQ spin-off company Vaxxas into their Nanopatch™ High-Density Microarray Patch (HD-MAP).

Working to identify cancer-causing genetic mutations for better cancer survival rates, the Australian Translational Genomics Centre is a partnership between QUT, Metro South Hospital and Health Service , and Pathology Queensland , and is one of the largest genomic diagnostic and research DNA sequencing services of its kind in Australasia.

Medical technology

Global medical technology group Stryker has established its first Australian research and development facility at the Herston Health Precinct in collaboration with The University of Queensland , Queensland University of Technology, Metro North Hospital and Health Service and the Queensland Government.

Contact the commercial partnership offices of Queensland universities and research institutes for details of their research-industry collaboration or investment opportunities.

Support for the health and medical industry in Queensland

Queensland’s health system.

The Department of Health is the lead government agency the state’s health system. It works in collaboration with 16 Hospital and Health Services (HHS) statutory bodies. Under the auspices of the Clinical Excellence Queensland , the Queensland Clinical Networks are formally recognised groups, established to improve the quality and efficiency of healthcare across 25 areas of care.

Sustained investment

Several of the HHS operate major tertiary research hospitals in close partnership with the many specialised research centres and health faculties of Queensland’s universities and research institutes such as the Translational Research Institute (TRI), QIMR Berghofer Medical Research Institute , Australian Institute of Tropical Health and Medicine and the Menzies Health Institute Queensland .

Successive Queensland Governments have developed several of these research hospitals and institutes over the last two decades. In 2022, further funding was announced for a new 150-bed Queensland Cancer Centre (A$750M) to be built within the Herston Health Precinct at Brisbane’s Royal Brisbane and Women’s Hospital in partnership with the University of Queensland – Herston , Queensland University of Technology and QIMR Berghofer Medical Research Institute . Also funded by the Queensland Government in 2022, is a medical manufacturing facility TM at TRI (A$60M of A$80M full cost) to be built in Brisbane. The facility will be equipped to produce promising drugs and vaccines for clinical trials.

UQ Australian Institute for Bioengineering and Nanotechnology – Illustration of blood clotting process

Photo credit: Dr Alexandr Kakinen

Biomedical industry

Queensland biomedical enterprises include biopharmaceuticals; generic pharmaceuticals; medical devices and point-of-care diagnostics; several multinational biomedical manufacturing businesses; and a thriving complementary medicines industry. The Queensland Biomedical 10-Year Roadmap and Action Plan released in June 2017 supports the continuing development the Queensland biomedical sector in the global value chain. The roadmap is supported by the Queensland Industry Partnership Program (2021–2025) that is investing A$350 million in several priority industry sectors including biomedical.

Institute for Molecular Bioscience investigates the stinging nettles of the world’s most venomous plants - the gympie-gympie tree

Photo credit: Darren Brown

Clinical trials

Queensland is a destination of choice for clinical trials, where it is far cheaper than the USA for early-phase clinical trials (28% cheaper before tax incentives and 60% after). Registered on the Queensland Clinical Trials Portal , one in five Australian clinical trials take place in Queensland across over 130 clinical trial sites.

CQUniversity Centre for Indigenous Health Equity Research co-design research projects with First Nations organisations

Research and innovation support

Advance Queensland is the key Queensland Government initiative (A$755 million allocated as of July 2022) delivered by nine government agencies, to develop entrepreneurial and research talent and to support start-ups and businesses. There are several funding programs , including the Industry Research Fellowships program that is.

The Department of Health’s HEALTHQ32 Research Strategy 2032 promotes partnerships between industry, research organisations and government to invest in innovative research. The searchable Database of Research Activity covers all human research undertaken in the Department of Health and includes research funded under the Advancing Clinical Research Fellowships , the Nursing and Midwifery Research Fellowships and other funding programs .

The majority of health and medical research in Australia is funded by two independent statutory agencies, the National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC) .

Talent pipeline for health and medical R&D

All of Queensland’s universities offer under and postgraduate courses and units in health and medicine and partner with Queensland’s research hospitals. Most of the universities host major research institutes and specialised research centres supporting post-graduate and dedicated researcher.

From their earliest years students in Queensland engage with STEM subjects (Science, Technology, Engineering and Mathematics) under the strategy for STEM in Queensland state schools and teachers access resources via the STEM Hub and the Queensland STEM Education Network provided by Queensland universities.

High school students can be industry-ready under the Gateway to Industry Schools Health (external link) program. This is long-term program to support the development of a highly-skilled workforce is delivered by CheckUP .

Queensland Life Sciences – Globally Competitive 04:47

Find out why top researchers and industry leaders are saying Queensland is one of the best places in the world for life science research.

View Queensland life sciences video with Chinese subtitles 昆士兰生命科学 – 全球领先”视频（附中文字幕）

The Department commissioned two reports to support emerging science-based industries:

• A New Chapter: opportunities to seed new industries for Queensland over the coming decade (2021) (PDF, 7.7MB)
• New Smarts Supporting Queensland’s knowledge-intensive industries through science, research and innovation (2019) (PDF, 11.9MB) .

Related news

Diabetes footcare project awarded $1.3m to evaluate novel rural outreach services.

The project, Queensland Diabetes Footcare Hubs (Q DFootHubs), has received $1,363,466.75 from the National Health and Medical Research Council (NHMRC) under its Partnership Projects program. The projects’ co-lead, QUT Associate Professor Peter Lazzarini, from the Australian Centre for Health Services Innovation (AusHSI) said the project’s overarching aim was to evaluate…

22 Aug 2024

Health & medical Social sciences

The changes to cell DNA that could revolutionise disease prevention

UQ researchers have discovered a mechanism in DNA that regulates how disease–causing mutations are inherited. Dr Anne Hahn and Associate Professor Steven Zuryn from UQ’s Queensland Brain Institute said the findings could provide a promising therapeutic avenue to stop the onset of heritable and age-related diseases.

Health & medical

NHMRC $1.3M grant to boost Indigenous health and wellbeing

A collaborative research project led by QUT and the Aboriginal and Torres Strait Islander Community Health Service (ATSICHS) Brisbane has been awarded $1,332,594.60 in funding through the 2023 NHMRC Partnerships Projects program. The four-year program of work aims to develop, implement and evaluate the impact of culturally appropriate, scalable tools…

AI tool to personalise brain stimulation therapy for major depression

A QIMR Berghofer-led consortium hopes to increase the overall effectiveness of brain stimulation for people with major depression by identifying which patients will best respond to the potentially life-changing treatment. Almost half of all people with major depression benefit from transcranial magnetic stimulation (TMS), a widely used non-invasive treatment that…

Digital economy Health & medical

Acounselling program originally designed to promote walking has improved the quality of life for sufferers of blocked leg arteries

Researchers have discovered a counselling program originally designed to promote walking has improved the quality of life for sufferers of blocked leg arteries and helped protect from its deadly effects – but not in the way anticipated. Professor Jonathan Golledge said that blocked leg arteries affect nearly one in five…

Potential new treatment pathway for bladder cancer

UQ research could lead to a more effective immunotherapy treatment against bladder cancer. A team led by Associate Professor Fernando Guimaraes from UQ’s Frazer Institute has found the mechanism used by bladder cancer to suppress the immune system’s natural killer (NK) cells.

21 Aug 2024

More health and medical news →

Strategic visualisation tool

Biomedical, and personalised and preventative healthcare

Traditional knowledge and biodiscovery in Queensland video

Watch the Traditional knowledge and biodiscovery in Queensland video to learn more about biodiscovery in Queensland and the importance of protecting traditional knowledge.

Page feedback

Website feedback

Please share your experience with this website’s content and functionality . For all other enquiries, comments and complaints , please contact us .

• Strongly agree
• Strongly disagree
• Your comments about this page’s content or functionality (required)
• Contact Please provide your email address or phone number if you are happy for us to contact you with any follow-up questions.

The Department of Environment, Science and Innovation collects personal information from you, including information about your email address and telephone number.

We collect this information to contact you with any follow-up questions. We will only use your information for this purpose. It will otherwise not be used or disclosed unless authorised or required by law. Your personal information will be handled in accordance with the Information Privacy Act 2009 .

UQmedicine magazine out now

Working together to improve health and empower communities through medical education and research..

The University of Queensland Medical School is a leading provider of medical education and research in Queensland, with an internationally renowned medical degree program, and with leading mental health and skin cancer programs. We're committed to pushing back the boundaries of knowledge, translating research into clinical practice and educating future generations.

• Year 1 medical students immerse themselves in rural and remote Queensland 20 August 2024
• Faculty of Medicine members recognised with awards by the Australian Medical Association 9 August 2024
• Violence against healthcare workers a global and growing problem 10 July 2024

Email:  [email protected]

Phone number: +61 7 3346 4922

Stay connected

Follow us on X  

Like us on Facebook

Join us on Instagram

Clinical Schools

• Greater Brisbane Clinical School
• Rural Clinical School
• Ochsner Clinical School

Our health and medical research improves children's health and wellbeing.

Our research

Discover how our research is improving health care for children and young people.

• Find a clinical trial or project, or read about past research we've been involved in on DoRA 2.0 - Queensland Health Database of Research Activity.
• Read more about our research achievements in our latest annual report .

Consumer engagement

We have consumers and community representatives who are members of the public, provide input and feedback to proposed research projects. Their involvement helps us make decisions about priorities, policies, and practices related to health research.

Research integrity

If you have a complaint, concern or question about research conducted at Children’s Health Queensland Hospital and Health Service please email [email protected] or contact the Patient Experience Team.

Research ethics and governance

If you're about to start a research project, find out about the application process and how to report on your project's progress.

Take part in research

When your child takes part in a clinical research trial, they’re helping to improve medical knowledge about the disease or condition and how we can treat it.

Partner with us

Learn about our research and how you can partner with us and play a vital role in the health and wellbeing of children and young people in Queensland.

Research stories

Discover some of the ways our researchers and partners are improving children's health.

Changing mindsets about down syndrome and sleep disorders

A study of sleep difficulties in children with Down Syndrome has revealed more needs to be done to empower families with the knowledge that sleep disruption isn’t just something they have to live with.

A benchmark for lung function in First Nations kids

A world-first study by respiratory researchers has delivered an accurate measure of lung function in Aboriginal and Torres Strait Islander children as they grow.

Taking a closer look at the cause of childhood strabismus

Researchers are unlocking the secrets behind intermittent exotropia, the most common, yet poorly understood, type of childhood strabismus.

Research contacts

Get in touch if you have any questions or would like more information about doing research with us.

Last updated:  July 2024

Health research

Queensland Health is continually conducting research to help enhance healthcare practices, fight disease and improve the quality and longevity of life. Patient information is needed for research to help improve the delivery of health services and increase our understanding of diseases, their treatments and side effects.

The Giving InFormation To Research (GIFTR) initiative gives patients admitted to certain Queensland public hospitals the option to consent for their medical information to be used in GIFTR health research.

This information may include:

• medical and personal information in their health record (including mental health, behavioural and sexual health and drug use)
• clinician notes
• test results (including x-rays and blood)
• genetic information.

The information will only be used for GIFTR approved research projects considered to be low risk and non-interventional. No information that could identify an individual is made public, and no physical participation is required.

For more information email [email protected] or visit Health records and personal information .

Last updated: 15 December 2015

The function " Store search " is only available to registered users.

Important information

Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.

Queensland Institute of Medical Research

Queensland Institute of Medical Research (QIMR)

About queensland institute of medical research.

QIMR is one of Australia's largest and most successful medical research institutes. Our researchers are investigating the genetic and environmental causes of more than 40 diseases as well as developing new diagnostics, better treatments and prevention strategies. The Institute's diverse research program extends from tropical diseases to cancers to indigenous health, mental health, obesity, HIV and asthma.

• Industry : Pharma

News about Queensland Institute of Medical Research

20-May-2010 | science

Australian researchers identify a new disease

Researchers at the Queensland Institute of Medical Research (QIMR) and the Royal Brisbane Women's Hospital have identified a previously undiagnosed ...

Here you will find Queensland Institute of Medical Research (QIMR)

© 1997-2024 LUMITOS AG, All rights reserved

You're viewing this site as a domestic an international student

You're a domestic student if you are:

• a citizen of Australia or New Zealand,
• an Australian permanent resident, or
• a holder of an Australian permanent humanitarian visa.

You're an international student if you are:

• intending to study on a student visa,
• not a citizen of Australia or New Zealand,
• not an Australian permanent resident, or
• a temporary resident (visa status) of Australia.

We have the answers to your postgraduate questions.

07 3346 9872

+61 7 3346 9872

 Send an enquiry

Email us, and we’ll get back to you as soon as possible.

Enquire now

Find an agent

Find a UQ agent near you.

How to apply

It’s easy, but there are a few things to consider.

Learn how to apply

Ready to apply?

Start today. Save for later if you need to.

Start application

Master of Medicine

This online program will provide you with the skills required to diagnose and manage skin cancer through a flexible structure that can fit around your existing schedule.

Through this 2 year part-time program, you'll gain the knowledge and skills required to diagnose and manage skin malignancy. You'll also consolidate your skills in the fields of clinical and dermatoscopic diagnosis and managing skin malignancies.

You can choose either clinical, research or public health pathways. As a graduate, you'll possess a high level of knowledge and diagnostic skills that will empower you to manage a large proportion of skin cancer cases. You can also use this knowledge in skin cancer research or skin cancer related policy and health promotion.

• understand the embryology, microanatomy, physiology, oncology and epidemiology of skin
• be able to undertake a consultation (history and examination) for a skin check
• demonstrate an ability to assess skin lesions through dermatoscopy and dermal imaging – and be competent in differential diagnosis
• confidently advise and manage most patients with skin cancer, using appropriate medical and therapeutic modalities in partnership with the patient
• possess a sound understanding of how to minimise indemnity risk in your practice
• know when to refer a patient for further opinion or more advanced treatment
• undertake research training, critically analyse current research in the field and apply this in professional practice.

Program highlights

• Gain in-demand expertise in the diagnosis and management of skin cancer.
• Benefit from a program that's fully delivered online, including readings, lectures, group discussions and case studies, with assessments and examinations also administered online.
• Join the leading provider of medical education and research in Queensland at UQ Medicine.

31 in the world for life sciences and medicine

QS World University Rankings 2024

1 in Queensland for life sciences and medicine

Fields of study

Tailor your studies to suit your goals. This program offers these options:

• Skin Cancer

See all fields of study

How you'll learn

Your learning experiences are designed to best suit the learning outcomes of the courses you choose.

• Online study

What you'll study

At UQ, degrees are called 'programs' and subjects are called 'courses'. Here's a sample of the courses you could study in this program:

• Clinical and Dermatoscopic Diagnosis in Skin Cancer Practice
• Assessment & Diagnosis
• Foundation Therapeutics
• Advanced Therapeutics

See courses and program structure

Career possibilities

Postgraduate study can take you anywhere. Depending on which field you choose, here are some of the careers you could be on your way to:

• General practitioner
• Hospital specialist

2 September

Science Research and Honours Week

Meet the expert: exploring nutrition education with Dr Olivia Wright

4-minute read

Is occupational therapy a good career?

Meet the expert: instilling confidence in future physiotherapists with Dr Roma Forbes

3-minute read

Entry requirements

To be eligible for entry, you'll need:

• a bachelor's degree (or equivalent) in medicine, plus 2 years full-time equivalent post qualification clinical practice, and
• you must have access to and have obtained any necessary permission for the use of appropriate and sufficient clinical cases in order to complete the program.

GPA equivalent

Select where you studied and your qualification to see the GPA equivalent you need to be considered for this program.

Use the GPA equivalent as a guide. When you apply, we’ll calculate your GPA using the UQ grading scale. Any failing grades will be included. Entry requirements are subject to change.

Equivalent subjects

Related programs

Depending on your previous qualifications and current goals, you might want to consider one of these related programs:

• Graduate Certificate in Medicine

English language requirements

TOEFL IBT (including Paper Edition) - Overall 100, listening 25, reading 25, writing 27, speaking 23.

PTE Academic - Overall 72, sub bands minimum 72.

BE - A minimum overall grade of 5 plus a minimum grade of A in all macro skills.

CES - Overall 185, All sub bands minimum 185.

OET - A minimum score of 350 in each sub-skill

There are other ways to meet the English language requirements. For some programs, additional conditions apply.

Learn how to meet the English language requirements

Student visas

This program does not meet the eligibility requirements for an Australian Student visa (subclass 500).

To study this program in Australia you will need a temporary visa or residency status with study entitlement. Some programs can also be studied from outside Australia.

Contact us for more information

Additional application information

By accepting this offer, applicants are confirming that they have access and any necessary permissions for the use of appropriate and sufficient clinical cases in order to facilitate the completion of the program.

This program is only offered in external mode. International students must study from their home country and will not be eligible for an Australian student visa. By accepting this offer, applicants are confirming that they have access and any necessary permissions for the use of appropriate and sufficient clinical cases in order to facilitate the completion of the program.

This program is designed to provide comprehensive training in the diagnosis and management of skin cancer. On completion, doctors will be able to effectively diagnose and manage the large majority of patients with skin cancer and associated conditions and also know when to refer a patient for more advanced treatment or further opinion.

There is a shortage of health practitioners with expert knowledge of skin cancer. With skin cancer being one of the most common forms of cancer, and with incidence increasing, the need for skilled diagnosis and treatment is growing.

For those interested in pursuing fellowship, this program helps prepare the theoretical aspects of skin cancer practice.

Fees and Scholarships

Indicative annual fee.

Approximate yearly cost of tuition (8 units). Your fees will vary according to your selected courses and study load. Fees are reviewed each year and may increase.

Fee information for 2025 is not yet available. Fee information displayed is for 2024.

Learn more about postgraduate fees

Approximate yearly cost of tuition (8 units). Your fees will vary according to your study load. Fees are reviewed each year and may increase.

AUD $25,280

Government assistance, financial aid.

As an international student, you might be eligible for financial aid – either from your home country, or from the Australian Government.

Learn more about financial aid

Domestic places in the Master of Medicine are Commonwealth Supported. This means the cost of your education is shared between you and the Australian Government.

Instead of tuition fees, Commonwealth Supported students pay what are called student contribution amounts.

HECS-HELP is an Australian Government loan scheme to assist eligible students with the cost of their student contribution amounts.

Learn more about HECS-HELP

Centrelink support

The Australian Government offers a number of income-support payments to eligible Australian university students.

Learn about Centrelink payments for students

Scholarships

You may be eligible for more than 100 scholarships, including:

Applying online

All international applications should be submitted to UQ. The program code for the Master of Medicine is  5398 . 

International students who want to study this program will not be eligible for a Student Visa (subclass 500). 

To study this program in Australia, you will need an Australian visa or residency status with sufficient study entitlement. Some programs can also be studied from outside Australia. 

Contact us with any questions  

All domestic applications should be submitted to UQ.

The program code for the Master of Medicine is 5398 .

Find out more about applying for postgraduate coursework study

Important dates

The closing date for this program is:

• To commence study in Semester 1 - January 16 of the year of commencement.
• To commence study in Semester 2 - June 16 of the year of commencement.

To learn more about UQ dates, including semester start dates, view the Academic Calendar .

Aboriginal and Torres Strait Islander applicants

For support with applying – or if you have any questions about university life – get in touch with our Aboriginal and Torres Strait Islander Studies Unit.

Contact the ATSIS Unit

Explore other programs

Express yourself. and your interest..

They say choosing a degree is hard, which is why we've made it easy. Register your interest and we'll send you everything you need to know about applying to UQ.

Sign up for updates

We will use your information to keep you informed about UQ programs, news, events and scholarships. By submitting this form, you consent to the terms of UQ's Marketing consent and privacy notice .

Make a donation via our online donation portal.

Direct Deposit

Paypal Giving Fund

Research Is Tomorrow's Hope

Here at Lions Medical Research Foundation, we are committed to start-up funding for world class medical research.

TRAVEL 4 RESEARCH

Medical Research

Since we began in 1963, Qld & Northern NSW Lions Medical Research Foundation has supported internationally recognised medical research by funding early career biomedical scientists. We support our researchers in making medical discoveries that benefit all Australians, by offering hope, and creating opportunities for everyone to live healthier and longer lives.

Donate Today

Our research has been in a variety of fields including immunology, Parkinson's disease, kidney disease, asthma, schizophrenia, diabetes, skin cancer, cervical and ovarian cancer, and many other areas.

The QLD & Northern NSW Lions Medical Research Foundation is a deductible gift recipient, so your donation will be tax-deductible.

Here's What Our Clients Have To Say

Lions medical research foundation.

Portman Place, 5/220 Boundary Street, Spring Hill

4.9 22 reviews

Get in Touch

Do you have a question for our team? Please leave us a message via the online contact form.

• Study with UniSQ
• University Degrees and courses

Bachelor of Biomedical Sciences (Medicine Pathway)

Email me a pdf copy of this degree.

UniSQ is collecting the personal information on this form for support for students and prospective students and for marketing purposes. Further information concerning privacy is available.

Download a copy

Hang in there.

We're generating your PDF...

Your download is ready

If your download doesn't start automatically click the link below. We will also send you an email with a link to your PDF if you entered your email address.

Something went wrong!

It looks like there was an error while generating your brochure. Please try again later.

• 3 years full-time

Career outcomes

Entry requirements, degree structure, fees and scholarships.

• Are you driven to make a difference with a career in medicine? UniSQ’s Bachelor of Biomedical Sciences (Medicine Pathway) prepares you for a rewarding study journey and for the Doctor of Medicine (MD) degree. 
• Upon successful completion of the degree within three years and with a minimum Grade Point Average of 5.0, you will gain direct entry into the University of Queensland’s (UQ) MD, delivered by the UQ Rural Clinical School, Toowoomba. 
• The Bachelor of Biomedical Sciences (Medicine Pathway) is part of the Darling Downs South West Medical Pathway, a collaboration between University of Southern Queensland, The University of Queensland, Darling Downs Health and South West Hospital and Health Service. The goal of the collaboration is to provide end to end medical training in the Darling Downs and South West Queensland regions to enhance our rural, regional and remote medical workforce.
• Your studies in the Medicine Pathway covers knowledge and skills in human anatomy and physiology, pathophysiology, pharmacology, biochemistry of nutrition, cell and molecular biology as well as cross-cultural and Indigenous psychology.
• Choose from one or two minors in pathology, haematology, microbiology and immunology, clinical chemistry, psychology, Indigenous studies, food and nutrition, molecular methods, and many more.
• Gain practical laboratory and technical skills that will allow you to understand complex scientific principles and apply these in your future medical career. 
• Have the opportunity to participate in undergraduate research experiences and/or undertake a semester abroad as an exchange student.
• Benefit from the practical experience of a two-week placement in a rural or regional community setting in Queensland, where you will learn from medical and healthcare staff and enhance your research and communication skills. 

Further study

Once you have successfully completed the Bachelor of Biomedical Sciences (Medicine Pathway) with a minimum GPA of 5.0, you will be eligible to enrol in UQ's MD degree. If you are unable to maintain the necessary GPA to transfer to the MD, you can use the credit from completed courses towards the Bachelor of Biomedical Sciences . 

• Graduates of the Bachelor of Biomedical Sciences (Medicine Pathway), who complete the degree within three years with a minimum GPA of 5.0, are eligible for direct entry into UQ’s Doctor of Medicine (MD). Graduates from the four-year MD degree will qualify as medical doctors. With further education and training, you can pursue a medical career  as a general practitioner, surgeon, patient assessor, public health manager, clinical academic, clinical research coordinator, international aid worker or defence force member.  
• As a Biomedical Sciences graduate you will be able to work as a researcher, science technician and fertility clinic scientist as well as pursue higher degree studies such as a Masters or PhD (following Honours).
• Must be completing year 12 in the year of applying (first year attempted). 
• Have achieved a minimum adjusted Australian Tertiary Admission Rank (ATAR) of 95 , or equivalent. Special adjustments to ATAR are available to eligible applicants via UniSQ’s Other admission considerations . A maximum of five (5) adjustment points can be applied to an applicant’s ATAR.
• Pre-requisite study : English, Literature, English and Literature Extension or English as an Additional Language (Units 3 and 4, C); General Mathematics, Mathematical Methods or Specialist Mathematics (Units 3 and 4, C)
• Recommended prior study:  one of Biology, Chemistry or Physics (Units 3 and 4, C)
• Must complete the University Clinical Aptitude Test for Australia and New Zealand (UCAT ANZ). The minimum required UCAT ANZ aggregate score depends on the performance of applicants and available places in the MD program. Shortlisted applicants from UCAT scores will also be required to attend multiple mini-interviews (MMIs). Find out more about selection criteria and the interview process for MMIs via UniSQ’s Other admission considerations  for this degree.
• An alternative admission pathway is available for students who identify as a First Nations person. Find out more via UniSQ’s Other admission considerations .

Please note:  Meeting the minimum entry requirements does not guarantee admission. Places within the Bachelor of Biomedical Sciences (Medicine Pathway) are limited by quota.

Deferment is not an available option for this degree.

English language requirements

You are required to satisfy the applicable English language requirements  and this degree requires a minimum of IELTS 6.5 or equivalent . If you do not meet the English language requirements you may apply to study a University-approved English language program .

To complete this degree students must complete 24 units.

Refer to the UniSQ Handbook for courses to be studied and recommended enrolment patterns.

Professional experience / placements

Practical experience is an integral component of the program and each student is required to undertake and satisfactorily complete 75 hours of practical experience. Every effort is made to accommodate student preference in terms of the location and timing of placements. However, students should be prepared for potential work/family inconvenience and the expense of travel and accommodation associated with professional placements outside of their preferred location. Note that Queensland-based students will not be expected to travel interstate.

Additional requirements for placements

All students must provide the following documents prior to commencing residential schools and clinical placements:

• UniSQ Student Declaration
• UniSQ Health Sciences Professional Readiness Modules
• Queensland Health Student Orientation Checklist
• Queensland Health Student Deed Poll
• Queensland Health iLearn Modules
• Blue Card 
• Australian Police Certificate

All students must also provide the following immunisation evidence prior to commencing clinical placements:

• Hepatitis B seroconversion
• Measles, Mumps, and Rubella immunisation evidence
• Varicella immunisation evidence
• Pertussis immunisation evidence
• Covid-19 immunisation evidence

Your actual fees may vary depending on the courses you select. We review our fees annually so these may be subject to change.

Approximate annual costs 1 for your first year of study (8 units) in this degree are:

1 These are indicative annual fees for 2024. 

Student services and amenities fees

You may need to pay student services and amenities (SA) fees  as part of your course costs.

Professional experience costs

This degree includes a professional experience component that may involve travel, accommodation and meal expenses.

Loan to help you pay your fees

You may not have to pay your course (subject) fees upfront. HECS-HELP and FEE-HELP allows you to defer your fees until your income reaches a certain level.  Find out if you are eligible for HECS-HELP or FEE-HELP .

You may also be eligible to receive financial support from Centrelink .

Scholarships

At UniSQ, we offer a range of scholarships to support your success at university. Find a scholarship  that works for you.

How to apply

Apply via qtac.

Complete your online application via QTAC (Queensland Tertiary Admissions Centre).

Please use the following QTAC codes to apply:

Copy your QTAC code and continue through to the QTAC website to complete your application.

* With the aim of providing more doctors in areas of workforce shortage in regional, rural and remote Australia, the Bonded Medical Program is available to eligible UniSQ Bachelor of Biomedical Sciences (Medical Pathway) graduates who have gained direct entry into the University of Queensland’s Doctor of Medicine. The Bonded Medical Program provides a Commonwealth Supported Place (CSP) in a medical course at an Australian university. In return, participants commit to work in an eligible regional, rural and remote area for 3 years after they complete their course.

Applications for the 2025 intake open on Thursday 1 August and close on Monday 30 September 2024.

Further information

Discover further information on applying to study at UniSQ that is relevant to you.

Got questions?

Begin your study journey today with the university rated 5/5 stars for graduates starting salaries* and start the degree that’s right for you.

*Good Universities Guide 2024

The entry requirements to study a biomedical science  to medicine degree will vary depending on the education provider you choose. To study UniSQ’s Bachelor Biomedical Sciences (Medicine Pathway) you need to meet the below entry requirements:

• completing year 12 in the year of applying
• a minimum ATAR
• subject pre-requisites
• recommended prior study
• completion of the University Clinical Aptitude Test for Australia and New Zealand. 

For more detailed information, please view the entry requirements section of this page. 

Many students go from studying biomedical science to medicine; if you’re thinking of doing this it’s also recommended that you investigate the entry requirements of your chosen medicine degree.

The duration of an undergraduate  medicine pathway degree will vary depending on which university you choose to study with. At UniSQ, a Bachelor of Biomedical Science (Medicine Pathway) will take you approximately three years to complete. This Science degree is only available to study full-time and we offer plenty of study support and learning resources  for you to thrive during your studies. 

Medical Genomics

Dr Nic Waddell

Group Leader & Cancer Program Coordinator

The Medical Genomics Team analyses next generation sequence data to address clinical challenges in a variety of diseases. The approaches we take include:

• characterising cancer genomes with short and long read sequencing
• classification of tumours into significant subtypes
• identification of mutational processes that underlie tumour development
• determining genomic and transcriptomic features associated with immune response

Ultimately, we aim to take steps towards ‘personalised medicine’ to enable the diagnosis, management and treatment of patients.

RESEARCH FOCUS

• Queensland Genomics

Since 2017, we have been part of the Queensland Genomics program exploring the Ethical, Legal and Social Implications (ELSI) of genomics within Queensland’s health system. Queensland Genomics is a Queensland Health initiative that seeks to accelerate the adoption of genomic medicine into mainstream healthcare to benefit all Queenslanders. In addition to her research work, Dr Waddell is an active advocate for patient perspective in genomic research. She is a member of the Queensland Genomics Community Group which advocates for the patient voice in medical genomics across Queensland.

In partnership with Queensland Genomics Dr Waddell and her team explore a variety of areas including:

• A variety of genomics projects based on community consultation and stakeholder engagement
• Improving accessibility of genetic health services for patients
• Developing guidelines for researchers partnering with Aboriginal and Torres Strait Islander peoples

Cancer Genomics

The Medical Genomics team works on a variety of tumour types gain a better understanding of disease biology, drug responses and to identify novel therapeutic strategies. Using whole-genome (long and short read), RNA sequencing and methylation technologies allows us to study disease heterogeneity and identify genomic signatures that can be used as biomarkers of treatment response.

The tumours which we study include melanoma, oesophageal cancer, breast cancer, ovarian cancer, mesothelioma and lung cancer. Our work is in collaboration with a variety of partners and some example of our work include:

Australia has one of the highest rates of melanoma in the world. Melanoma is a type of skin cancer usually caused by overexposure to the sun. Rarer forms of melanoma can also occur on body sites without sun exposure, such the inside of the eye (uveal), on the soles of the feet (acral) and internally on mucous membranes such as inside the mouth (mucosal melanoma).  

The Medical Genomics laboratory is part of the Australian Melanoma Genome Project , which involves more than 50 researchers from Melanoma Institute Australia, The University of Sydney, Royal Prince Alfred Hospital, Westmead Institute for Medical Research and QIMR Berghofer Medical Research Institute (involving the Medical Genomics, Genome Informatics and Oncogenomics groups). In this project, we are using whole genome sequencing technologies to identify common genetic mutations in melanoma tumours from more than 500 patients. It is hoped that discovering such information will help doctors to better personalise the treatment of melanoma. 

• Lung cancer and Mesothelioma

Lung cancer is a common disease and many patients have a poor survival. We are studying the genomics of lung cancer to identify therapeutic targets including those that are associated with immunotherapy response. We are part of a large national lung cancer project led by the Royal Brisbane and Women’s Hospital (RBWH) that is recruiting patients for whole genome and RNA sequencing. This project aims to improve diagnoses of cancers and determine why some patients respond well to immunotherapy while others do not.

• Gynaecological Cancers

Part of our research focuses on the study of gynaecological cancers, including ovarian and endometrial cancers. This is done through comprehensive genomic analysis of pre-clinical models as well as public data.

Diagnosing Inherited Disease

We use whole genome sequencing to identify germline events which may be contributing to disease.

The Medical Genomics team is currently analysing sequence data within the Hereditary Cancer Syndromes ICCon (Inherited Cancer Connect) project. The ICCon partnership is a Cancer Council NSW-funded national collaboration of Familial Cancer Centres. It aims to identify genetic variants in the normal DNA of patients with a suspected familial cancer syndrome and who have previously received uninformative genetic testing. Simple and complex genetic changes are looked for and assessed from a targeted panel of 101 genes of which are known to cause familial cancer. These changes are reported back to the patient’s treating clinicians.

The ICCon project is part of the Australian Genomics Health Alliance ( Australian Genomics ). Australian Genomics is a collaboration of more than 80 organisations, both nationally and internationally, which aims to integrate genomic medicine into mainstream healthcare. Australian Genomics launched in 2016 with the award of a $25 million grant from the NHMRC entitled Target Call for Research into Preparing Australia for the Genomics Revolution in Healthcare .

Cancer Immunotherapy

The Medical Genomics team is characterising genetic determinants underlying response and resistance to cancer immunotherapy. Through whole genome and RNA sequencing, we are able to identify tumor specific neoantigens that can elicit T-cell responses in cancers. Through Immunogenomics, we are able to understand the genomics of tumor cells and the properties of immune cells in the tumour microenvironment. Through further research we can uncover how tumours may prevent immune attack and why. We seek to better understand the tumour microenvironment and how it may contribute towards tumour growth. Lastly, we can uncover new techniques in patient screening to see who would benefit most from immunotherapies during the treatment of their disease.

Diseases & Conditions

• Skin Cancer
• Breast Cancer
• Ovarian Cancer
• Oesophageal Cancer
• Pancreatic Cancer
• Endometrial Cancer
• Mesothelioma Cancer
• Pancreatic Neuroendocrine Cancer
• Brain Cancer
• Colorectal Cancer
• Lung Cancer

Staff & Collaborators

• Alan Robertson , PhD Student
• Dr Bonnie Wong, Bioinform Research Officer
• Dr Felicity Newell , Bioinformatician
• Dr Georgina Hollway , Clinical Genome Scientist
• Dr Jia Zhang, Bioinformatician
• Dr Katia Nones , Senior Research Officer
• Khoa Tran, PhD Student
• Miranda Vidgen , Research Officer
• Dr Nic Waddell , Group Leader
• Rebecca Johnston , Bioinformatician
• Ross Koufariotis , Scientific Technical Officer
• Sandra Brosda, Visiting Scientist
• Sharon Hoyte, Bioinformatician
• Sowmya Sharma, PhD Student
• Vanessa Lakis , Bioinformatician, Research Officer
• Dr Venkateswar Addala , Research Officer

Internal Collaborators

• Professor Amanda Spurdle , Molecular Cancer Epidemiology
• Dr Ann-Marie Patch , Clinical Genomics & Genomic Informatics 
• Professor Bryan Day , Sid Faithfull Brain Cancer Laboratory
• Professor Georgia Chenevix-Trench , Cancer Genetics
• Greg Pratt , Aboriginal and Torres Strait Islander Health
• Professor Harsha Gowda , Cancer Precision Medicine 
• Dr James Hudson , Cardiac Bioengineering
• John Pearson , Genome Informatics
• Professor Juliet French , Functional Genetics
• Professor Louisa Gordon , Health Economics
• Professor Nick Hayward , Oncogenomics
• Professor Stacey Edwards , Functional Cancer Genomics
• Professor Steven Lane , Gordon and Jessie Gilmour Leukaemia Research Laboratory
• Dr Vicki Whitehall , Conjoint Gastroenterology

External Collaborators

• Andrew Barbour, PA hospital and The University of Queensland
• Aldo Scarpa, University of Verona
• Australian Genomics
• Bruce Robinson, Jenette Creaney and Anna Nowak, NCARD and University of WA
• Claire Scott, WEHI
• David Fielding, RBWH
• genomiQa Pty Ltd
• Graham Mann, MIA
• Julie McGaghgran, Genetic Health QLD
• Max Kelsen, Brisbane
• Pam Pollock, QUT
• Peter Simpson, UQCCR, The University of Queensland
• Sean Grimmond, VCCC, University of Melbourne
• Sunil Lakhani, UQCCR, The University of Queensland

Funding Support

We gratefully acknowledge the support of the following funding organisations, funding bodies and donors:

• Cancer Australia
• Cancer Council Queensland
• Ian Potter Foundation
• Keith Boden Fellowship
• National Health and Medical Research Council (NHMRC)
• QIMR Berghofer

The Medical Genomics Group are taking steps towards ‘personalised medicine’ to enable the diagnosis, management and treatment of cancer patients

The team analyses next generation sequence data to address clinical challenges in a variety of diseases

Dr Nic Waddell heads the Medical Genomics team at QIMR Berghofer

STUDENT PROJECTS

Somatic changes to mitochondria dna in cancer development.

This project is suitable for Honours, Masters, MPhil, MD or PhD student. Background Mitochondria are membrane-bound cell organelles that are critical for energy production and cell metabolism. Mitochondria are located in the cytoplasm of cells and have their own DNA that is circular and approximately 17 kb. Aberrant mitochondrial function is a key component of […]

Programs and services

Learn about Queensland’s state-funded mental health, alcohol and other drug programs and services.

Mental health and wellbeing programs and services

Mental health services in queensland.

Find Queensland's public, private and non-government organisation mental health and wellbeing support services.

Mental health community support services

Learn about Queensland's adult, non-clinical, recovery focused psychosocial wraparound support services delivered through non-government organisations.

Child and youth mental health programs

Find out about our new Head to Health Kids – Queensland mental health services in Brisbane and the Gold Coast.

Queensland Health Court Liaison Service

Learn how we support the Magistrates Court for people charged with offences who have a mental illness.

Alcohol and other drug programs and services

Residential rehabilitation and withdrawal treatment services.

We're investing in and building new rehabilitation centres to help people who are experiencing problematic substance use. Learn more and find the locations.

Alcohol and drug support services

Find Queensland's public, private and non-government organisation support services for problematic substance use.

Take Home Naloxone program

Learn about the Take Home Naloxone program and how to register as an authorised alternative supplier to access and supply naloxone.

Queensland opioid treatment program

Learn how the opioid treatment program works or find out how to apply for prescriber approval from Queensland Health.

Drug checking services

We're investing in drug checking services to reduce harm in our community. Learn more and read the requirements for providers who offer drug checking services.

Drug and alcohol diversion programs

We provide the health response for Queensland's drug diversion programs. Learn more about the program and find out what we do.

Queensland needle and syringe program

Our needle and syringe program aims to reduce blood-borne viruses and injection-related injuries and diseases. Learn more and find locations to access and dispose of injecting equipment.

Last updated: 23 August 2024